Compare Stocks

→ The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
LGVN Longeveron	$1.67 -2.9%	$3.76	$1.60 ▼ $44.00	$4.19M	0.21	1.64 million shs	321,800 shs
SBTX Silverback Therapeutics	$8.09 -2.1%	$8.82	$2.80 ▼ $8.97	$291.71M	0.6	337,931 shs	534,599 shs
VRP Invesco Variable Rate Preferred ETF	$23.48 -0.2%	$23.62	$21.36 ▼ $23.87	$1.60B	0.23	353,718 shs	239,724 shs

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
LGVN Longeveron	-2.91%	-16.92%	-51.58%	-79.02%	-94.04%
SBTX Silverback Therapeutics	-2.06%	-10.71%	-19.10%	+24.08%	+24.46%
VRP Invesco Variable Rate Preferred ETF	-0.17%	-0.17%	-1.39%	-0.15%	+5.86%

Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)

The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.

See why the elites are pouring billions into gold.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
LGVN Longeveron	2.8299 of 5 stars	3.5	2.0	0.0	0.0	3.0	3.3	0.6
SBTX Silverback Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
VRP Invesco Variable Rate Preferred ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
LGVN Longeveron	3.00	Buy	$60.00	3,492.81% Upside
SBTX Silverback Therapeutics	N/A	N/A	N/A	N/A
VRP Invesco Variable Rate Preferred ETF	0.00	N/A	N/A	N/A

Current Analyst Ratings

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
LGVN Longeveron	$710K	5.90	N/A	N/A	$2.68 per share	0.62
SBTX Silverback Therapeutics	N/A	N/A	N/A	N/A	$7.41 per share	N/A
VRP Invesco Variable Rate Preferred ETF	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
LGVN Longeveron	-$21.41M	-$10.20	N/A	N/A	N/A	-3,020.17%	-209.14%	-136.82%	5/10/2024 (Estimated)
SBTX Silverback Therapeutics	-$89.48M	-$2.42	N/A	∞	N/A	N/A	-29.62%	-28.20%	N/A
VRP Invesco Variable Rate Preferred ETF	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Latest LGVN, VRP, MDG1, SBTX, and C4XD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
2/27/2024	Q4 2023	LGVN Longeveron	-$2.10	-$2.50	-$0.40	-$0.25	$0.21 million	$0.06 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
LGVN Longeveron	N/A	N/A	N/A	N/A	N/A
SBTX Silverback Therapeutics	N/A	N/A	N/A	N/A	N/A
VRP Invesco Variable Rate Preferred ETF	$1.22	5.20%	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
LGVN Longeveron	0.21	1.50	1.50
SBTX Silverback Therapeutics	N/A	67.87	67.87
VRP Invesco Variable Rate Preferred ETF	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
LGVN Longeveron	10.01%
SBTX Silverback Therapeutics	74.89%
VRP Invesco Variable Rate Preferred ETF	N/A

Insider Ownership

Company	Insider Ownership
LGVN Longeveron	24.34%
SBTX Silverback Therapeutics	34.40%
VRP Invesco Variable Rate Preferred ETF	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
LGVN Longeveron	23	2.51 million	1.90 million	Not Optionable
SBTX Silverback Therapeutics	83	36.06 million	23.65 million	Not Optionable
VRP Invesco Variable Rate Preferred ETF	N/A	68.10 million	N/A	Not Optionable

LGVN, VRP, MDG1, SBTX, and C4XD Headlines

Source	Headline
	Invesco Variable Rate Preferred ETF declares monthly distribution of $0.1109 msn.com - April 22 at 3:27 PM
	Invesco Variable Rate Preferred ETF declares monthly distribution of $0.1064 msn.com - March 19 at 8:10 AM
	Invesco Variable Rate Preferred ETF declares monthly distribution of $0.1020 msn.com - February 20 at 7:14 AM
	Invesco Variable Rate Preferred ETF declares monthly distribution of $0.1667 msn.com - December 18 at 1:57 PM
	Invesco Variable Rate Preferred ETF declares monthly distribution of $0.1668 msn.com - November 22 at 8:34 AM
	NPFD: Expensive Fund With Hidden Fixed-Rate Exposure msn.com - November 1 at 11:29 PM
	Invesco Variable Rate Preferred ETF declares monthly distribution of $0.1052 seekingalpha.com - September 18 at 10:03 AM
	Invesco Variable Rate Preferred ETF declares monthly distribution of $0.1231 msn.com - July 24 at 3:01 PM
	Invesco Variable Rate Preferred ETF declares monthly distribution of $0.1213 msn.com - June 20 at 8:41 PM
	Invesco Variable Rate Preferred ETF declares monthly distribution of $0.1157 seekingalpha.com - May 22 at 7:42 PM
	Invesco Variable Rate Preferred ETF declares monthly distribution of $0.1136 msn.com - April 24 at 3:33 PM
	Invesco Variable Rate Preferred ETF declares monthly distribution of $0.1105 msn.com - February 20 at 12:36 PM
	Invesco Variable Rate Preferred (VRP) Shares Cross Above 200 DMA nasdaq.com - January 10 at 7:50 PM
	Invesco Financial Preferred ETF (ARCA:PGF), Quotes and News Summary benzinga.com - January 5 at 7:59 AM
	Invesco Variable Rate Investment Grade ETF declares monthly distribution of $0.1234 msn.com - December 20 at 6:33 PM
	Invesco Preferred ETF declares monthly distribution of $0.0613 msn.com - December 20 at 1:33 PM
	Invesco Variable Rate Preferred ETF declares monthly distribution of $0.1021 msn.com - December 20 at 1:33 PM
	VRIG Invesco Actively Managed Exchange-Traded Fund Trust - Invesco Variable Rate Investment Grade ETF seekingalpha.com - October 1 at 2:43 PM
	Invesco Variable Rate Preferred ETF declares monthly distribution of $0.0896 seekingalpha.com - September 21 at 10:25 PM
	Invesco Variable Rate Preferred ETF declares monthly distribution of $0.1094 seekingalpha.com - July 20 at 12:02 AM
	Invesco Variable Rate Preferred ETF declares monthly distribution of $0.0979 seekingalpha.com - May 23 at 4:26 PM
	Shares of VRP Now Oversold nasdaq.com - May 2 at 10:31 PM
	Invesco Variable Rate Preferred ETF declares monthly distribution of $0.0975 seekingalpha.com - April 18 at 5:58 PM
	The Right Way to Consider Preferred Stocks as Rates Rise nasdaq.com - March 28 at 6:07 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Longeveron

NASDAQ:LGVN

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young, healthy adult donors. It is conducting Phase 1, Phase 2a, and Phase 2b clinical trials in various indications, such as aging-related frailty, alzheimer's disease, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is headquartered in Miami, Florida.

Silverback Therapeutics

NASDAQ:SBTX

Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverback Therapeutics, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Invesco Variable Rate Preferred ETF

NYSEARCA:VRP

The Invesco Variable Rate Preferred ETF (VRP) is an exchange-traded fund that mostly invests in broad credit fixed income. The fund tracks a market-value-weighted index of variable- and floating-rate preferred stocks. VRP was launched on May 1, 2014 and is managed by Invesco.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial